The ULS23 Challenge: a Baseline Model and Benchmark Dataset for 3D Universal Lesion Segmentation in Computed Tomography

• URL: http://arxiv.org/abs/2406.05231v2
• Date: Fri, 21 Jun 2024 09:23:17 GMT
• Title: The ULS23 Challenge: a Baseline Model and Benchmark Dataset for 3D Universal Lesion Segmentation in Computed Tomography
• Authors: M. J. J. de Grauw, E. Th. Scholten, E. J. Smit, M. J. C. M. Rutten, M. Prokop, B. van Ginneken, A. Hering,
• Abstract summary: We introduce the ULS23 benchmark for 3D universal lesion segmentation in chest-abdomen-pelvis CT examinations. The ULS23 training dataset contains 38,693 lesions across this region, including challenging pancreatic, colon and bone lesions.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Size measurements of tumor manifestations on follow-up CT examinations are crucial for evaluating treatment outcomes in cancer patients. Efficient lesion segmentation can speed up these radiological workflows. While numerous benchmarks and challenges address lesion segmentation in specific organs like the liver, kidneys, and lungs, the larger variety of lesion types encountered in clinical practice demands a more universal approach. To address this gap, we introduced the ULS23 benchmark for 3D universal lesion segmentation in chest-abdomen-pelvis CT examinations. The ULS23 training dataset contains 38,693 lesions across this region, including challenging pancreatic, colon and bone lesions. For evaluation purposes, we curated a dataset comprising 775 lesions from 284 patients. Each of these lesions was identified as a target lesion in a clinical context, ensuring diversity and clinical relevance within this dataset. The ULS23 benchmark is publicly accessible via uls23.grand-challenge.org, enabling researchers worldwide to assess the performance of their segmentation methods. Furthermore, we have developed and publicly released our baseline semi-supervised 3D lesion segmentation model. This model achieved an average Dice coefficient of 0.703 $\pm$ 0.240 on the challenge test set. We invite ongoing submissions to advance the development of future ULS models.

Related papers

• ISLES'24: Improving final infarct prediction in ischemic stroke using multimodal imaging and clinical data [3.2816454618159008]
  This work presents the ISLES'24 challenge, which addresses final post-treatment stroke infarct prediction from pre-interventional acute stroke imaging and clinical data. The contributions of this work are two-fold: first, we introduce a standardized benchmarking of final stroke infarct segmentation algorithms through the ISLES'24 challenge; second, we provide insights into infarct segmentation using multimodal imaging and clinical data strategies.
  arXiv  Detail & Related papers  (2024-08-20T16:01:05Z)
• Advanced Tumor Segmentation in Medical Imaging: An Ensemble Approach for BraTS 2023 Adult Glioma and Pediatric Tumor Tasks [0.8184931154670512]
  This study outlines our methodology for segmenting tumors in the context of two distinct tasks from the BraTS 2023 challenge: Adult Glioma and Pediatric Tumors. Our approach leverages two encoder-decoder-based CNN models, namely SegResNet and MedNeXt, for segmenting three distinct subregions of tumors. Our proposed approach achieves third place in the BraTS 2023 Adult Glioma Challenges with an average of 0.8313 and 36.38 Dice and HD95 scores on the test set, respectively.
  arXiv  Detail & Related papers  (2024-03-14T10:37:41Z)
• Segmentation of Mediastinal Lymph Nodes in CT with Anatomical Priors [2.087440644034646]
  Lymph nodes (LNs) in the chest have a tendency to enlarge due to various pathologies, such as lung cancer or pneumonia. We propose to segment LNs in the mediastinum by leveraging the anatomical priors of 28 different structures. CT volumes from 89 patients available in the public NIH CT Lymph Node dataset were used to train three 3D nnUNet models to segment LNs.
  arXiv  Detail & Related papers  (2024-01-11T21:59:42Z)
• Exploring 3D U-Net Training Configurations and Post-Processing Strategies for the MICCAI 2023 Kidney and Tumor Segmentation Challenge [16.189621599350684]
  In 2023, it is estimated that 81,800 kidney cancer cases will be newly diagnosed, and 14,890 people will die from this cancer in the United States. There exists inter-observer variability due to subtle differences in the imaging features of kidney and kidney tumors.
  arXiv  Detail & Related papers  (2023-12-09T10:42:50Z)
• Federated Learning Enables Big Data for Rare Cancer Boundary Detection [98.5549882883963]
  We present findings from the largest Federated ML study to-date, involving data from 71 healthcare institutions across 6 continents. We generate an automatic tumor boundary detector for the rare disease of glioblastoma. We demonstrate a 33% improvement over a publicly trained model to delineate the surgically targetable tumor, and 23% improvement over the tumor's entire extent.
  arXiv  Detail & Related papers  (2022-04-22T17:27:00Z)
• Advancing COVID-19 Diagnosis with Privacy-Preserving Collaboration in Artificial Intelligence [79.038671794961]
  We launch the Unified CT-COVID AI Diagnostic Initiative (UCADI), where the AI model can be distributedly trained and independently executed at each host institution. Our study is based on 9,573 chest computed tomography scans (CTs) from 3,336 patients collected from 23 hospitals located in China and the UK.
  arXiv  Detail & Related papers  (2021-11-18T00:43:41Z)
• CoRSAI: A System for Robust Interpretation of CT Scans of COVID-19 Patients Using Deep Learning [133.87426554801252]
  We adopted an approach based on using an ensemble of deep convolutionalneural networks for segmentation of lung CT scans. Using our models we are able to segment the lesions, evaluatepatients dynamics, estimate relative volume of lungs affected by lesions and evaluate the lung damage stage.
  arXiv  Detail & Related papers  (2021-05-25T12:06:55Z)
• Classification supporting COVID-19 diagnostics based on patient survey data [82.41449972618423]
  logistic regression and XGBoost classifiers, that allow for effective screening of patients for COVID-19 were generated. The obtained classification models provided the basis for the DECODE service (decode.polsl.pl), which can serve as support in screening patients with COVID-19 disease. This data set consists of more than 3,000 examples is based on questionnaires collected at a hospital in Poland.
  arXiv  Detail & Related papers  (2020-11-24T17:44:01Z)
• M3Lung-Sys: A Deep Learning System for Multi-Class Lung Pneumonia Screening from CT Imaging [85.00066186644466]
  We propose a Multi-task Multi-slice Deep Learning System (M3Lung-Sys) for multi-class lung pneumonia screening from CT imaging. In addition to distinguish COVID-19 from Healthy, H1N1, and CAP cases, our M 3 Lung-Sys also be able to locate the areas of relevant lesions.
  arXiv  Detail & Related papers  (2020-10-07T06:22:24Z)
• Detecting Scatteredly-Distributed, Small, andCritically Important Objects in 3D OncologyImaging via Decision Stratification [23.075722503902714]
  We focus on the detection and segmentation of oncology-significant (or suspicious cancer metastasized) lymph nodes. We propose a divide-and-conquer decision stratification approach that divides OSLNs into tumor-proximal and tumor-distal categories. We present a novel global-local network (GLNet) that combines high-level lesion characteristics with features learned from localized 3D image patches.
  arXiv  Detail & Related papers  (2020-05-27T23:12:11Z)
• VerSe: A Vertebrae Labelling and Segmentation Benchmark for Multi-detector CT Images [121.31355003451152]
  Large Scale Vertebrae Challenge (VerSe) was organised in conjunction with the International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI) in 2019 and 2020. We present the the results of this evaluation and further investigate the performance-variation at vertebra-level, scan-level, and at different fields-of-view.
  arXiv  Detail & Related papers  (2020-01-24T21:09:18Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.